Return to homepagePandemic Pact

Humoral immunity & human monoclonal antibodies against SARS-CoV-2

  • Funded by Institut Pasteur International Network (IPIN)
  • Total publications:0 publications

Grant number: 157392

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021

  • Funder

    Institut Pasteur International Network (IPIN)

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

About The objective of this research project is to understand the molecular and functional basis of the memory B-cell antibody response to the SARS-CoV-2 Spike protein. One of the key goals of this research program is to make use of this knowledge to develop new therapeutic strategies, particularly immunotherapies using potent SARS-CoV-2 neutralizing antibodies that we anticipate isolating from infected donors who entered in remission.